Shandong Lukang Pharmaceutical Co Ltd
Shandong Lukang Pharmaceutical Co.,Ltd. operates as a pharmaceutical company in China. The company provides analgesics and antipyretics; gastrointestinal; endocrine; cardio-cerebrovascular; anti-infective; and other human formulation products. It offers human and veterinary active pharmaceutical ingredient; veterinary formulation; bio-pesticides; and amino acid. The company also exports its produ… Read more
Shandong Lukang Pharmaceutical Co Ltd - Asset Resilience Ratio
Shandong Lukang Pharmaceutical Co Ltd (600789) has an Asset Resilience Ratio of 0.01% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2009–2024)
This chart shows how Shandong Lukang Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Shandong Lukang Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥1.22 Million | 0.01% |
| Total Liquid Assets | CN¥1.22 Million | 0.01% |
Asset Resilience Insights
- Limited Liquidity: Shandong Lukang Pharmaceutical Co Ltd maintains only 0.01% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Shandong Lukang Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio
Compare Shandong Lukang Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Kamada
NASDAQ:KMDA |
Drug Manufacturers - Specialty & Generic | 21.63% |
|
Dongwha Pharm.Co.Ltd
KO:000020 |
Drug Manufacturers - Specialty & Generic | 1.92% |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078 |
Drug Manufacturers - Specialty & Generic | 0.46% |
|
Yuhan Corp.
KO:000100 |
Drug Manufacturers - Specialty & Generic | 0.99% |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153 |
Drug Manufacturers - Specialty & Generic | 1.81% |
|
Kotra Industries Bhd
KLSE:0002 |
Drug Manufacturers - Specialty & Generic | 9.82% |
|
Yuyu Pharma
KO:000220 |
Drug Manufacturers - Specialty & Generic | 1.74% |
|
Ildong Holdings Co Ltd
KO:000230 |
Drug Manufacturers - Specialty & Generic | 1.57% |
Annual Asset Resilience Ratio for Shandong Lukang Pharmaceutical Co Ltd (2009–2024)
The table below shows the annual Asset Resilience Ratio data for Shandong Lukang Pharmaceutical Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 0.01% | CN¥1.22 Million | CN¥9.10 Billion | 0.00pp |
| 2023-12-31 | 0.01% | CN¥1.19 Million | CN¥8.80 Billion | 0.00pp |
| 2022-12-31 | 0.01% | CN¥1.26 Million | CN¥8.73 Billion | 0.00pp |
| 2021-12-31 | 0.02% | CN¥1.21 Million | CN¥7.79 Billion | +0.00pp |
| 2020-12-31 | 0.02% | CN¥1.09 Million | CN¥7.27 Billion | 0.00pp |
| 2019-12-31 | 0.02% | CN¥1.15 Million | CN¥7.09 Billion | +0.00pp |
| 2018-12-31 | 0.02% | CN¥1.05 Million | CN¥6.57 Billion | -0.01pp |
| 2017-12-31 | 0.03% | CN¥1.53 Million | CN¥5.20 Billion | -0.02pp |
| 2016-12-31 | 0.05% | CN¥1.96 Million | CN¥4.18 Billion | -0.02pp |
| 2015-12-31 | 0.06% | CN¥2.57 Million | CN¥4.02 Billion | +0.02pp |
| 2014-12-31 | 0.04% | CN¥1.77 Million | CN¥4.08 Billion | -0.19pp |
| 2013-12-31 | 0.23% | CN¥9.50 Million | CN¥4.07 Billion | +0.20pp |
| 2012-12-31 | 0.03% | CN¥1.13 Million | CN¥3.99 Billion | +0.00pp |
| 2011-12-31 | 0.03% | CN¥956.94K | CN¥3.48 Billion | -0.02pp |
| 2010-12-31 | 0.05% | CN¥1.47 Million | CN¥3.03 Billion | +0.00pp |
| 2009-12-31 | 0.05% | CN¥1.19 Million | CN¥2.48 Billion | -- |